CBP Sets New Date for FDA Processing of Port of Entry Changes in ACE
FDA expects to begin processing port of entry changes through ACE's production environment "no earlier than" Sept. 9, CBP said in a CSMS message Aug. 14. An additional CSMS message will be sent out near Sept. 9 to either confirm or provide an update on the "planned deployment date," the message said. CBP had announced earlier this year that it began testing the change in its certification environment (see 2303030055).
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
CBP added that the FDA "will only send an acknowledgment of a PoE change for PGA lines with the full message set. An acknowledgement will not be sent for FDA disclaimed lines." FDA and CBP said they "appreciate the testing conducted thus far and encourage trade to continue testing in CERT."